Publication | Closed Access

Platelet/Lymphocyte Ratio Is Superior to Neutrophil/Lymphocyte Ratio as a Predictor of Chemotherapy Response and Disease-free Survival in Luminal B-like (HER2−) Breast Cancer

Hematological MalignancyPlatelet/lymphocyte RatioChemotherapy ResponseBreast OncologyMedicineImmunologyBreast CancerCancer TreatmentOncologyRadiation OncologyCancer Research